🇺🇸 CitraFleet in United States

86 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 86

Most-reported reactions

1. Hyponatraemia — 22 reports (25.58%)
2. Rhabdomyolysis — 16 reports (18.6%)
3. Metabolic Encephalopathy — 10 reports (11.63%)
4. Altered State Of Consciousness — 6 reports (6.98%)
5. Disorientation — 6 reports (6.98%)
6. Hyporesponsive To Stimuli — 6 reports (6.98%)
7. Acute Kidney Injury — 5 reports (5.81%)
8. Confusional State — 5 reports (5.81%)
9. Diarrhoea — 5 reports (5.81%)
10. Fatigue — 5 reports (5.81%)

Source database →

Frequently asked questions

Is CitraFleet approved in United States?

CitraFleet does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for CitraFleet in United States?

Norgine is the originator. The local marketing authorisation holder may differ — check the official source linked above.